Valeant Offers to Buy Allergan With Pershing's Support

Dr. Keith A. Marcus draws Allergan Inc. Botox into a syringe before administering it to a patient at the offices of Marcus Facial Plastic Surgery in Redondo Beach, California, U.S., on Tuesday, April 22, 2014. Valeant Pharmaceuticals International Inc. offered to buy Allergan Inc., maker of the Botox wrinkle treatment, in a cash-and-stock deal valued at $45.7 billion in the latest step of the Canadian company's plan to become one of the world's largest drugmakers. Photographer: Patrick T. Fallon/Bloomberg via Getty Images
Dr. Keith A. Marcus draws Allergan Inc. Botox into a syringe before administering it to a patient at the offices of Marcus Facial Plastic Surgery in Redondo Beach, California, U.S., on Tuesday, April 22, 2014. Valeant Pharmaceuticals International Inc. offered to buy Allergan Inc., maker of the Botox wrinkle treatment, in a cash-and-stock deal valued at $45.7 billion in the latest step of the Canadian company's plan to become one of the world's largest drugmakers. Photographer: Patrick T. Fallon/Bloomberg via Getty Images
Valeant Offers to Buy Allergan With Pershing's Support
COMPRAR UMA LICENÇA
Como posso usar esta imagem?
R$ 3.000,00
BRL

DETALHES

Restrições:
Contate o escritório local para todos os usos comerciais ou promocionais.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
ID Editorial:
486159811
Coleção:
Bloomberg
Data da criação:
22 de abril de 2014
Data do upload:
Tipo de licença:
Direitos controlados
Info sobre autorização:
Sem autorização Mais informações
Fonte:
Bloomberg
Nome do objeto:
VALEANT ALLERGAN
Tamanho máximo do arquivo:
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 3 MB